Disorder of O-xylosylglycan synthesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309450
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of O-xylosylglycan synthesis is a group of very rare genetic conditions that affect how the body builds certain sugar chains (called glycosaminoglycans or proteoglycans) that are attached to proteins. These sugar chains are essential building blocks for connective tissues throughout the body, including bones, cartilage, skin, and joints. The process begins when a sugar called xylose is attached to a protein, and then additional sugars are added in a specific sequence. When any of the enzymes responsible for these steps do not work properly due to gene mutations, the resulting proteoglycans are abnormal or deficient. Patients with these disorders often show problems with skeletal development, including short stature, joint looseness or contractures, and distinctive facial features. Some individuals may also have skin that is unusually stretchy or fragile, eye problems, hearing loss, or developmental delays. The severity can vary widely depending on which specific gene is affected and the nature of the mutation. There is currently no cure for disorders of O-xylosylglycan synthesis. Treatment is supportive and focuses on managing individual symptoms. This may include orthopedic care for bone and joint problems, physical therapy, pain management, and monitoring for complications. Because these conditions are so rare, research is still ongoing to better understand the full range of symptoms and to develop more targeted therapies.

Key symptoms:

Short statureJoint hypermobility or loose jointsJoint contractures or stiffnessSkeletal abnormalitiesDistinctive facial featuresStretchy or fragile skinDelayed bone developmentIntellectual disability or developmental delayHearing lossVision problemsCurved spine (scoliosis or kyphosis)Dislocated jointsMuscle weaknessAbnormal wound healing

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Disorder of O-xylosylglycan synthesis.

View clinical trials →

No actively recruiting trials found for Disorder of O-xylosylglycan synthesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Disorder of O-xylosylglycan synthesis community →

No specialists are currently listed for Disorder of O-xylosylglycan synthesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of O-xylosylglycan synthesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of O-xylosylglycan synthesisForum →

No community posts yet. Be the first to share your experience with Disorder of O-xylosylglycan synthesis.

Start the conversation →

Latest news about Disorder of O-xylosylglycan synthesis

No recent news articles for Disorder of O-xylosylglycan synthesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific gene is affected in my child's case, and what does that mean for their outlook?,What specialists should we see regularly, and how often?,Are there any physical activities we should avoid to protect the joints?,What signs of complications should we watch for at home?,Are there any clinical trials or research studies we could participate in?,What early intervention services would benefit my child's development?,Should other family members be tested for this condition?

Common questions about Disorder of O-xylosylglycan synthesis

What is Disorder of O-xylosylglycan synthesis?

Disorder of O-xylosylglycan synthesis is a group of very rare genetic conditions that affect how the body builds certain sugar chains (called glycosaminoglycans or proteoglycans) that are attached to proteins. These sugar chains are essential building blocks for connective tissues throughout the body, including bones, cartilage, skin, and joints. The process begins when a sugar called xylose is attached to a protein, and then additional sugars are added in a specific sequence. When any of the enzymes responsible for these steps do not work properly due to gene mutations, the resulting proteogl

How is Disorder of O-xylosylglycan synthesis inherited?

Disorder of O-xylosylglycan synthesis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Disorder of O-xylosylglycan synthesis typically begin?

Typical onset of Disorder of O-xylosylglycan synthesis is neonatal. Age of onset can vary across affected individuals.